High Tower Advisors, LLC Guardant Health, Inc. Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 50,730 shares of GH stock, worth $2.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,730

Previous 50,458 0.54%

Holding current value

$2.38 Million

Previous $1.46 Million 20.18%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$22.3 - $36.29 $6,065 - $9,870	272 Added 0.54%	50,730 $1.16 Million
Q2 2024 Aug 13, 2024	SELL	$16.07 - $31.84 $5,849 - $11,589	-364 Reduced 0.72%	50,458 $1.46 Million
Q1 2024 May 06, 2024	SELL	$17.13 - $26.91 $511,827 - $804,043	-29,879 Reduced 37.02%	50,822 $1.05 Million
Q4 2023 Feb 12, 2024	SELL	$21.58 - $29.5 $42,339 - $57,879	-1,962 Reduced 2.37%	80,701 $2.18 Million
Q3 2023 Nov 08, 2023	SELL	$25.8 - $39.97 $37,487 - $58,076	-1,453 Reduced 1.73%	82,663 $2.45 Million
Q2 2023 Aug 14, 2023	SELL	$20.94 - $38.01 $151,940 - $275,800	-7,256 Reduced 7.94%	84,116 $3.01 Million
Q1 2023 May 11, 2023	BUY	$22.92 - $33.76 $702,314 - $1.03 Million	30,642 Added 50.46%	91,372 $2.14 Million
Q4 2022 Feb 08, 2023	SELL	$25.44 - $59.78 $112,495 - $264,347	-4,422 Reduced 6.79%	60,730 $1.65 Million
Q3 2022 Nov 09, 2022	SELL	$43.66 - $61.0 $66,275 - $92,598	-1,518 Reduced 2.28%	65,152 $3.51 Million
Q2 2022 Aug 10, 2022	SELL	$28.82 - $77.35 $80,148 - $215,110	-2,781 Reduced 4.0%	66,670 $2.69 Million
Q1 2022 May 12, 2022	SELL	$48.25 - $100.49 $72,568 - $151,136	-1,504 Reduced 2.12%	69,451 $4.6 Million
Q4 2021 Feb 10, 2022	SELL	$88.71 - $120.43 $273,581 - $371,406	-3,084 Reduced 4.17%	70,955 $7.1 Million
Q3 2021 Nov 12, 2021	BUY	$98.77 - $132.17 $435,872 - $583,266	4,413 Added 6.34%	74,039 $9.26 Million
Q2 2021 Aug 06, 2021	BUY	$109.77 - $165.68 $62,898 - $94,934	573 Added 0.83%	69,626 $8.64 Million
Q1 2021 May 10, 2021	SELL	$127.04 - $179.1 $445,275 - $627,745	-3,505 Reduced 4.83%	69,053 $10.5 Million
Q4 2020 Feb 10, 2021	BUY	$99.96 - $135.93 $766,693 - $1.04 Million	7,670 Added 11.82%	72,558 $9.35 Million
Q3 2020 Nov 13, 2020	BUY	$80.32 - $111.8 $227,787 - $317,064	2,836 Added 4.57%	64,888 $7.25 Million
Q2 2020 Aug 10, 2020	BUY	$60.49 - $97.5 $101,865 - $164,190	1,684 Added 2.79%	62,052 $5.03 Million
Q1 2020 May 21, 2020	SELL	$59.04 - $88.81 $309,074 - $464,920	-5,235 Reduced 7.98%	60,368 $4.2 Million
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $320,948 - $446,598	5,395 Added 8.96%	65,603 $5.13 Million
Q3 2019 Nov 12, 2019	BUY	$62.59 - $110.3 $178,694 - $314,906	2,855 Added 4.98%	60,208 $3.84 Million
Q2 2019 Aug 13, 2019	BUY	$63.94 - $91.11 $3.67 Million - $5.23 Million	57,353 New	57,353 $4.95 Million

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.8B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Guardant Health, Inc. Transaction History